KURE vs. BSCQ
KURE (KraneShares MSCI All China Health Care Index ETF) and BSCQ (Invesco BulletShares 2026 Corporate Bond ETF) are both exchange-traded funds - KURE is a China Equities fund tracking the MSCI China All Shares Health Care 10/40 Index, while BSCQ is a Corporate Bonds fund tracking the NASDAQ BulletShares USD Corporate Bond 2026 Index. Both are passively managed. Over the past 5 years, KURE returned -16.60%/yr vs 1.53%/yr for BSCQ. At a 0.06 correlation, their price movements are largely independent. KURE charges 0.65%/yr vs 0.10%/yr for BSCQ.
Performance
KURE vs. BSCQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KURE achieves a -12.73% return, which is significantly lower than BSCQ's 1.68% return.
KURE
- 1D
- 1.16%
- 1M
- -7.47%
- YTD
- -12.73%
- 6M
- -15.99%
- 1Y
- -6.42%
- 3Y*
- -4.03%
- 5Y*
- -16.60%
- 10Y*
- —
BSCQ
- 1D
- -0.03%
- 1M
- 0.25%
- YTD
- 1.68%
- 6M
- 1.81%
- 1Y
- 4.25%
- 3Y*
- 5.17%
- 5Y*
- 1.53%
- 10Y*
- —
KURE vs. BSCQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
KURE KraneShares MSCI All China Health Care Index ETF | -12.73% | 24.87% | -17.83% | -17.70% | -25.43% | -16.01% | 68.97% | 34.30% | -30.01% |
BSCQ Invesco BulletShares 2026 Corporate Bond ETF | 1.68% | 5.02% | 4.86% | 5.71% | -8.31% | -1.68% | 9.41% | 13.94% | -0.94% |
Correlation
The correlation between KURE and BSCQ is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2018 | 0.06 |
The correlation between KURE and BSCQ shifts across timeframes, from -0.07 (1 year) to 0.07 (5 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KURE vs. BSCQ — Risk / Return Rank
KURE
BSCQ
KURE vs. BSCQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KraneShares MSCI All China Health Care Index ETF (KURE) and Invesco BulletShares 2026 Corporate Bond ETF (BSCQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KURE | BSCQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -7.28 | ||
| Sortino ratioReturn per unit of downside risk | -15.75 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 3.43 | -2.45 |
| Calmar ratioReturn relative to maximum drawdown | -0.21 | 41.77 | -41.98 |
| Martin ratioReturn relative to average drawdown | -0.44 | 181.80 | -182.24 |
Loading charts...
Drawdowns
KURE vs. BSCQ - Drawdown Comparison
The maximum KURE drawdown since its inception was -68.53%, which is greater than BSCQ's maximum drawdown of -16.50%. Use the drawdown chart below to compare losses from any high point for KURE and BSCQ.
Loading charts...
Drawdown Indicators
| KURE | BSCQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.53% | -16.50% | -52.03% |
Max Drawdown (1Y)Largest decline over 1 year | -30.88% | -0.10% | -30.78% |
Max Drawdown (3Y)Largest decline over 3 years | -34.05% | -1.13% | -32.92% |
Max Drawdown (5Y)Largest decline over 5 years | -67.94% | -13.02% | -54.92% |
Current DrawdownCurrent decline from peak | -62.00% | -0.03% | -61.97% |
Average DrawdownAverage peak-to-trough decline | -38.19% | -2.84% | -35.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.53% | 0.02% | +14.51% |
Volatility
KURE vs. BSCQ - Volatility Comparison
KraneShares MSCI All China Health Care Index ETF (KURE) has a higher volatility of 7.61% compared to Invesco BulletShares 2026 Corporate Bond ETF (BSCQ) at 0.13%. This indicates that KURE's price experiences larger fluctuations and is considered to be riskier than BSCQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KURE | BSCQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.61% | 0.13% | +7.48% |
Volatility (6M)Calculated over the trailing 6-month period | 18.19% | 0.43% | +17.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.25% | 0.61% | +25.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.86% | 3.29% | +28.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.34% | 4.75% | +27.59% |
KURE vs. BSCQ - Expense Ratio Comparison
KURE has a 0.65% expense ratio, which is higher than BSCQ's 0.10% expense ratio.
Dividends
KURE vs. BSCQ - Dividend Comparison
KURE's dividend yield for the trailing twelve months is around 4.81%, more than BSCQ's 4.46% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
BSCQ Invesco BulletShares 2026 Corporate Bond ETF | 4.46% | 4.14% | 4.05% | 3.53% | 2.54% | 1.91% | 2.42% | 2.96% | 3.32% | 2.92% | 0.51% |
KURE KraneShares MSCI All China Health Care Index ETF | 4.81% | 4.19% | 1.29% | 0.65% | 0.05% | 14.12% | 0.00% | 0.25% | 0.21% | 0.00% | 0.00% |
Frequently Asked Questions
KURE and BSCQ have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KURE has higher volatility (7.61%) compared to BSCQ (0.13%). In terms of maximum drawdown, KURE dropped -68.53% vs BSCQ's -16.50%.
On 5-year performance, BSCQ leads with 1.53% vs -16.60% for KURE. On fees, BSCQ is cheaper at 0.10% per year. On volatility, BSCQ has been the lower-risk option at 0.13%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BSCQ has performed better with a 1.53% return vs -16.60%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BSCQ is cheaper with a 0.10% expense ratio, compared with 0.65% for KURE.
KURE has the higher dividend yield at 4.81%, compared with 4.46% for BSCQ.
KURE is categorized as China Equities, while BSCQ is Corporate Bonds. KURE tracks MSCI China All Shares Health Care 10/40 Index, while BSCQ tracks NASDAQ BulletShares USD Corporate Bond 2026 Index. They also come from different issuers: CICC and Invesco. Their fees differ too: 0.65% for KURE and 0.10% for BSCQ.
BSCQ currently has the higher Sharpe Ratio (7.04 vs -0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KURE and BSCQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer